Safety Study of Anti-Influenza Virus Monoclonal Antibody to Treat Influenza
Clinical trial NCT01390025 · COMPLETED
Trial details
- NCT number
- NCT01390025
- Sponsor
- Theraclone Sciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2012-03-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.